Cargando…

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer

The aim was to evaluate serum levels of circulating cell-free nucleosomes (ccfn) containing a variety of epigenetic signals including 5-methylcytosine DNA, histone modifications H3K9Me3, H3K9Ac, H3S10PO4, H3K36Me3, H4K20Me3, H4PanAc and pH2AX, nucleosome variant H2AZ and nucleosome adducts with HMGB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Louise, Christensen, Ib Jarle, Herzog, Marielle, Micallef, Jake, Nielsen, Hans Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828191/ https://www.ncbi.nlm.nih.gov/pubmed/29535803 http://dx.doi.org/10.18632/oncotarget.21908

Ejemplares similares

Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020)

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
por: Rahier, Jean-François, et al.
Publicado: (2017)

Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012)

Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
por: Ørntoft, Mai‐Britt Worm, et al.
Publicado: (2020)

Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals
por: Thorsen, Stine Buch, et al.
Publicado: (2013)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
por: Vižin, Tjaša, et al.
Publicado: (2014)

Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2023)

Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers
por: Rasmussen, Louise, et al.
Publicado: (2016)

Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
por: Nielsen, Boye Schnack, et al.
Publicado: (2010)

A novel proteomics approach to epigenetic profiling of circulating nucleosomes
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2021)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019)

Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
por: Post, Carolin, et al.
Publicado: (2002)

Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
por: Illemann, Martin, et al.
Publicado: (2014)

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
por: Dolin, Troels Gammeltoft, et al.
Publicado: (2021)

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
por: Cavalier, Etienne, et al.
Publicado: (2021)

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures
por: Ungerer, Vida, et al.
Publicado: (2021)

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
por: Gezer, Ugur, et al.
Publicado: (2015)

Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer
por: Thorsen, Stine F., et al.
Publicado: (2019)

SDPS-13 CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA
por: Decarpentrie, Jonathan, et al.
Publicado: (2023)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer
por: Ostenfeld, Marie Stampe, et al.
Publicado: (2016)

Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
por: Morimont, Laure, et al.
Publicado: (2022)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients
por: Ito, Hiroaki, et al.
Publicado: (2015)

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
por: Fahmueller, Yvonne Nadine, et al.
Publicado: (2012)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

Screening for colorectal cancer: possible improvements by risk assessment evaluation?
por: Nielsen, Hans J, et al.
Publicado: (2011)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer
por: Wilson-Robles, Heather, et al.
Publicado: (2020)

Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
por: Smith, David Hersi, et al.
Publicado: (2014)

A new nucleosomic-based model to identify and diagnose SSc-ILD
por: Guiot, Julien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1onp44rlbd5tl4c6t4t2f9fdpc